No Data
Barclays Moves to the Sidelines on Homebuilders on Potential Downside to Margins
This D.R. Horton Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday
Oppenheimer Maintains D.R. Horton(DHI.US) With Hold Rating
D.R. Horton Analyst Ratings
Barclays Downgrades D.R. Horton(DHI.US) to Hold Rating, Cuts Target Price to $170
Express News | DR Horton Inc : Barclays Cuts to Equalweight From Overweight; Cuts Target Price to $170 From $192
loading...